Biography
![Alex Schnapp Alex Schnapp](/-/media/people/s/schnapp_alex.jpg?h=255&w=255&hash=BEB75030687F7BD069395C8F12B157CC)
Alex Schnapp is an associate in Weil’s Mergers & Acquisitions practice and is based in New York. Alex participates in the representation of public and private companies in mergers, acquisitions and divestitures.
Alex has been part of the teams advising:
- Glencore, CPP Investments and BC, as shareholders, in Viterra Ltd.’s approximately $18 billion business combination with Bunge Ltd.
- Iron Mountain Incorporated in its acquisition of Regency Technologies
- Sanofi in its $2.9 billion acquisition of Provention Bio Inc. and its approximately $2.2 billion acquisition of Inhibrx, Inc.
Prior to joining Weil, Alex was a Corporate associate at another international law firm.
Alex received his J.D. from the Benjamin N. Cardozo School of Law and his B.A. from Duke University.
Firm News & Announcements, Firm News & Announcements, Latest Thinking
Firm News & Announcements
- Weil Advises AMC in Major Liability Management Refinancing Transactions to Extend Up To $2.45 Billion of Debt Maturities Deal Brief — July 24, 2024
- Weil Advises Sanofi in its Acquisition of Inhibrx, Inc. Deal Brief — January 23, 2024